Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review
Rhyne, Christopher, Cohen, Joshua M, Seminerio, Michael J, Carr, Karen, Krasenbaum, Lynda J
Published in Medicine (Baltimore) (09.06.2023)
Published in Medicine (Baltimore) (09.06.2023)
Get full text
Journal Article
Real-world reductions in monthly migraine days and healthcare resource utilisation in UK patients using fremanezumab
Shazia, Afridi, Todor, Totev, Lynda, Krasenbaum, Emi, Terasawa, Hasan, Akcicek, Dalbir, Dhiraj, Rochelle, Sun, Binyam, Yilma, Maurice, Driessen
Published in Journal of neurology, neurosurgery and psychiatry (28.11.2023)
Published in Journal of neurology, neurosurgery and psychiatry (28.11.2023)
Get full text
Journal Article
Immunogenicity of biologic therapies for migraine: a review of current evidence
Cohen, Joshua M., Ning, Xiaoping, Kessler, Yoel, Rasamoelisolo, Michele, Campos, Verena Ramirez, Seminerio, Michael J., Krasenbaum, Lynda J., Shen, Honglue, Stratton, Jennifer
Published in Journal of headache and pain (07.01.2021)
Published in Journal of headache and pain (07.01.2021)
Get full text
Journal Article
Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
McAllister, Peter, Lamerato, Lois, Krasenbaum, Lynda J., Cohen, Joshua M., Tangirala, Krishna, Thompson, Stephen, Driessen, Maurice, Casciano, Julian, Dotiwala, Zenobia, Mauskop, Alexander
Published in Journal of headache and pain (20.12.2021)
Published in Journal of headache and pain (20.12.2021)
Get full text
Journal Article
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Published in Journal of headache and pain (24.11.2021)
Published in Journal of headache and pain (24.11.2021)
Get full text
Journal Article
A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
Krasenbaum, Lynda J., Pedarla, Vasantha L., Thompson, Stephen F., Tangirala, Krishna, Cohen, Joshua M., Driessen, Maurice T.
Published in Journal of headache and pain (04.05.2022)
Published in Journal of headache and pain (04.05.2022)
Get full text
Journal Article
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study
Ahmed, Zubair, Honomichl, Ryan, Thompson, Stephen F., Cohen, Joshua M., Schuster, Andrew, Thompson, Nicolas R., Lapin, Brittany, Udeh, Belinda L., Ramirez Campos, Verena, Krasenbaum, Lynda J., Katzan, Irene L.
Published in Headache (01.07.2023)
Published in Headache (01.07.2023)
Get full text
Journal Article
Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine
Mackenzie, Kimberly D, Ortega, Mario, Kessler, Yoel, Campos, Verena Ramirez, Krasenbaum, Lynda J, Carr, Karen, Ning, Xiaoping, Stratton, Jennifer
Published in Frontiers in physiology (29.11.2022)
Published in Frontiers in physiology (29.11.2022)
Get full text
Journal Article
Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020
Barash, Steve, Ramirez Campos, Verena, Ning, Xiaoping, Driessen, Maurice T., Krasenbaum, Lynda J., Carr, Karen, Cohen, Joshua M.
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.11.2021)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.11.2021)
Get full text
Journal Article
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Published in Journal of headache and pain (17.05.2022)
Published in Journal of headache and pain (17.05.2022)
Get full text
Journal Article